Genome-scale CRISPR screening for modifiers of cellular LDL uptake.
暂无分享,去创建一个
[1] Jérémie Rossy,et al. Membrane Heterogeneity Controls Cellular Endocytic Trafficking , 2020, Frontiers in Cell and Developmental Biology.
[2] B. Collins,et al. Recognising the signals for endosomal trafficking. , 2020, Current opinion in cell biology.
[3] Jie Luo,et al. Mechanisms and regulation of cholesterol homeostasis , 2019, Nature Reviews Molecular Cell Biology.
[4] Kendall R. Sanson,et al. Optimized libraries for CRISPR-Cas9 genetic screens with multiple modalities , 2018, Nature Communications.
[5] Anushya Muruganujan,et al. PANTHER version 14: more genomes, a new PANTHER GO-slim and improvements in enrichment analysis tools , 2018, Nucleic Acids Res..
[6] N. Naslavsky,et al. The enigmatic endosome – sorting the ins and outs of endocytic trafficking , 2018, Journal of Cell Science.
[7] P. Natarajan,et al. Insights from population-based analyses of plasma lipids across the allele frequency spectrum. , 2018, Current opinion in genetics & development.
[8] A. Gingras,et al. The cargo receptor SURF4 promotes the efficient cellular secretion of PCSK9 , 2018, bioRxiv.
[9] F. Kraemer,et al. Scavenger receptor B type 1: expression, molecular regulation, and cholesterol transport function , 2018, Journal of Lipid Research.
[10] R. Hegele,et al. Polygenic influences on dyslipidemias , 2018, Current opinion in lipidology.
[11] David Henriques,et al. Systems Pharmacology Dissection of Cholesterol Regulation Reveals Determinants of Large Pharmacodynamic Variability between Cell Lines , 2017, Cell systems.
[12] Lars G Fritsche,et al. Efficiently controlling for case-control imbalance and sample relatedness in large-scale genetic association studies , 2017, Nature Genetics.
[13] R. Sessions,et al. Retriever is a multiprotein complex for retromer-independent endosomal cargo recycling , 2017, Nature Cell Biology.
[14] N. Sirisena,et al. Genetic determinants of inherited susceptibility to hypercholesterolemia – a comprehensive literature review , 2017, Lipids in Health and Disease.
[15] Lale Tokgözoğlu,et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel , 2017, European heart journal.
[16] C. Ramírez,et al. Genome-wide RNAi screen reveals ALK1 mediates LDL uptake and transcytosis in endothelial cells , 2016, Nature Communications.
[17] Barbara Plecko,et al. CCC- and WASH-mediated endosomal sorting of LDLR is required for normal clearance of circulating LDL , 2016, Nature Communications.
[18] Wei Guo,et al. The Exocyst at a Glance , 2015, Journal of Cell Science.
[19] Neville E. Sanjana,et al. High-throughput functional genomics using CRISPR–Cas9 , 2015, Nature Reviews Genetics.
[20] J. Goldstein,et al. A Century of Cholesterol and Coronaries: From Plaques to Genes to Statins , 2015, Cell.
[21] P. Elliott,et al. UK Biobank: An Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old Age , 2015, PLoS medicine.
[22] Gerald F. Watts,et al. Homozigot ailevi hiperkolesterolemi: klinisyenlerin taniyi ve klinik yönetimi gelistirmelerine yönelik yeni anlayislar ve rehberlik. Avrupa Ateroskleroz Dernegi'nin Ailevi Hiperkolesterolemi Üzerine Uzlasi Paneli yazili görüsü. , 2015 .
[23] Jun S. Liu,et al. MAGeCK enables robust identification of essential genes from genome-scale CRISPR/Cas9 knockout screens , 2014, Genome Biology.
[24] B. van Steensel,et al. Easy quantitative assessment of genome editing by sequence trace decomposition , 2014, Nucleic acids research.
[25] Neville E. Sanjana,et al. Improved vectors and genome-wide libraries for CRISPR screening , 2014, Nature Methods.
[26] Tanya M. Teslovich,et al. Discovery and refinement of loci associated with lipid levels , 2013, Nature Genetics.
[27] D. Srivastava,et al. Genetics of Human Cardiovascular Disease , 2012, Cell.
[28] P. Tontonoz,et al. LXR Regulates Cholesterol Uptake Through Idol-Dependent Ubiquitination of the LDL Receptor , 2009, Science.
[29] B. Fehse,et al. A multicolor panel of novel lentiviral "gene ontology" (LeGO) vectors for functional gene analysis. , 2008, Molecular Therapy.
[30] Jonathan C. Cohen,et al. Molecular biology of PCSK9: its role in LDL metabolism. , 2007, Trends in biochemical sciences.
[31] Simon C Watkins,et al. A single common portal for clathrin-mediated endocytosis of distinct cargo governed by cargo-selective adaptors. , 2006, Molecular biology of the cell.
[32] Jonathan D. Cohen,et al. Monogenic hypercholesterolemia: new insights in pathogenesis and treatment. , 2003, The Journal of clinical investigation.
[33] W. J. Kent,et al. The UCSC Genome Browser , 2003, Current protocols in bioinformatics.
[34] Joseph L Goldstein,et al. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. , 2002, The Journal of clinical investigation.
[35] R. Scheller,et al. Sec6/8 Complex Is Recruited to Cell–Cell Contacts and Specifies Transport Vesicle Delivery to the Basal-Lateral Membrane in Epithelial Cells , 1998, Cell.
[36] J. Goldstein,et al. The SREBP Pathway: Regulation of Cholesterol Metabolism by Proteolysis of a Membrane-Bound Transcription Factor , 1997, Cell.
[37] F. Maxfield,et al. Quantification of low density lipoprotein and transferrin endocytic sorting HEp2 cells using confocal microscopy. , 1994, Journal of cell science.
[38] F. Maxfield,et al. Iterative fractionation of recycling receptors from lysosomally destined ligands in an early sorting endosome , 1989, The Journal of cell biology.
[39] T. Yamane,et al. Growth of human hepatoma cells lines with differentiated functions in chemically defined medium. , 1982, Cancer research.
[40] R. Schekman,et al. Identification of 23 complementation groups required for post-translational events in the yeast secretory pathway , 1980, Cell.